FARP2 Antibodies

Santa Cruz Biotechnology features a diverse variety of FARP2 monoclonal antibodies for investigating FARP2 in cellular signaling pathways. FARP2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FARP2, or FERM domain-containing protein 2, functions as a key regulator of actin dynamics and cell adhesion, significantly influencing cell migration and signal transduction. FARP2's role in modulating Rho GTPase activity highlights its significance in various physiological and pathological conditions, including cancer progression and immune responses. Studying FARP2 through specific molecular tools can reveal essential insights into complex biological processes. Researchers worldwide rely on FARP2 monoclonal antibodies to advance their understanding of cellular mechanisms. Advanced research techniques and protocols enable precise detection and analysis of FARP2 expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific knowledge and potential therapeutic developments.